About Symic Biomedical
Symic Biomedical is a company based in San Francisco (United States) founded in 2012.. Symic Biomedical has raised $82.65 million across 10 funding rounds from investors including NIH, HHS and QB3. Symic Biomedical operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$82.65 M (USD)
in 10 rounds
-
Latest Funding Round
$11 M (USD), Series B
Apr 26, 2019
-
Investors
NIH
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Symic Biomedical
Symic Biomedical has successfully raised a total of $82.65M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $11 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $11.0M
-
First Round
First Round
(15 Sep 2013)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Series B - Symic Biomedical | Valuation | Cell Innovation Partners |
|
| May, 2017 | Amount | Series B - Symic Biomedical | Valuation | HEDA Ventures |
|
| Dec, 2015 | Amount | Series A - Symic Biomedical | Valuation | Lilly Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Symic Biomedical
Symic Biomedical has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and QB3. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Geintech Technologies is engaged in manufacturing high-standard communication cables.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences investments are targeted in the healthcare sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Symic Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Symic Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Symic Biomedical Comparisons
Competitors of Symic Biomedical
Symic Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Symic Biomedical
Frequently Asked Questions about Symic Biomedical
When was Symic Biomedical founded?
Symic Biomedical was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Symic Biomedical located?
Symic Biomedical is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Symic Biomedical a funded company?
Symic Biomedical is a funded company, having raised a total of $82.65M across 10 funding rounds to date. The company's 1st funding round was a Series A of $25.28M, raised on Sep 15, 2013.
What does Symic Biomedical do?
Symic Biomedical was founded in 2012 and is based in San Francisco, United States. Operations focus on the biomedical sector, where compounds are developed to prevent tissue degradation and support healing in cases of illness or injury. The pipeline features SB-061, targeted at osteoarthritis, and SB-0303, addressed to peripheral vascular disease, vein graft failure, fibrosis, and cancer. Activities center on advancing these therapeutic candidates through research and development.
Who are the top competitors of Symic Biomedical?
Symic Biomedical's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Symic Biomedical's investors?
Symic Biomedical has 12 investors. Key investors include NIH, HHS, QB3, Cell Innovation Partners, and Geintech Technologies.